Global Data Intelligence Center |
구분 |
보고서 (영문) |
업로드 날짜 |
제약/바이오/임상시험 |
Post Hoc Analysis from Large Randomized Trial Shows Inpefa Safe and Effective in HF Pre- and Post-Discharge |
08-15-2023 |
Imugene Licenses Potential First-to-Market Allogeneic CAR T Cell Therapy in Blood Cancer |
08-17-2023 |
Pfizer’s First-Ever Bispecific Antibody Drug Elrexfio Holds Promise in Multiple Myeloma |
08-25-2023 |
Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US |
08-25-2023 |
European PFAS Ban Would Burden Drug Companies and Packagers |
08-28-2023 |
FDA Sees Potential in Zelasudil for the Treatment of Idiopathic Pulmonary Fibrosis |
08-29-2023 |
질환별 |
vWD Market Growth Driven by the Increasing Use of Recombinant vWF |
08-15-2023 |
Sex-Specific Cardiovascular Disease Risk Across the Whole Glycemic Spectrum |
08-15-2023 |
COVID-19 Vaccines: Opportunity Assessment and Forecast |
08-18-2023 |
Diffuse Large B-Cell Lymphoma (DLBCL): Competitive Landscape |
08-21-2023 |
Diabetic Macular Edema Market Expected to Reach $9.6 Billion Across 7MM by 2031 |
08-24-2023 |
Diabetic Macular Edema: 68- Market Analysis and Sales Forecast |
08-24-2023 |
기타 |
House Democrats Unveil New Legislation That Expands the Inflation Reduction Act |
08-11-2023 |
WHO Advocates for the Integration of Traditional Medicine in Conventional Healthcare |
08-24-2023 |